HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Janesh K Gupta Selected Research

Levonorgestrel (Plan B)

10/2015A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial.
11/2013LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study.
7/2013Predictive ability of estrogen receptor (ER), progesterone receptor (PR), COX-2, Mlh1, and Bcl-2 expressions for regression and relapse of endometrial hyperplasia treated with LNG-IUS: a prospective cohort study.
6/2013Prediction of regression and relapse of endometrial hyperplasia with conservative therapy.
5/2013Relapse of endometrial hyperplasia after conservative treatment: a cohort study with long-term follow-up.
12/2010Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis.
3/2010Prognostic significance of estrogen and progesterone receptor expression in LNG-IUS (Mirena) treatment of endometrial hyperplasia: an immunohistochemical study.
8/2008The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Janesh K Gupta Research Topics

Disease

9Endometrial Hyperplasia
11/2013 - 04/2006
6Hyperplasia
11/2013 - 08/2008
5Leiomyoma (Uterine Fibroids)
01/2014 - 01/2002
3Endometrial Neoplasms (Endometrial Cancer)
11/2013 - 04/2006
2Menorrhagia
10/2015 - 03/2006
2Pain (Aches)
01/2013 - 01/2010
1Leiomyosarcoma
01/2014
1Neoplasms (Cancer)
05/2013
1Postoperative Pain
01/2013
1Amenorrhea
01/2011
1Hemorrhage
01/2011
1Endometriosis (Adenomyosis)
02/2009
1Myoma
02/2009
1Bacteriuria
08/2006
1Bacterial Vaginosis
08/2006
1Premature Birth (Birth, Premature)
08/2002

Drug/Important Bio-Agent (IBA)

8Levonorgestrel (Plan B)FDA LinkGeneric
10/2015 - 08/2008
6Progestins (Progestagens)IBA
11/2013 - 08/2008
2Progesterone Receptors (Progesterone Receptor)IBA
07/2013 - 03/2010
2Estrogens (Estrogen)FDA Link
07/2013 - 03/2010
1Biological Markers (Surrogate Marker)IBA
07/2013
1antineoplaston A10 (A 10)IBA
01/2013
1Morphine (MS Contin)FDA LinkGeneric
01/2013
1Estrogen Receptor alphaIBA
03/2010
1tranilast (N 5')IBA
03/2010
1Aromatase (CYP19)IBA
03/2010
1tensins (tensin)IBA
03/2010
1Carbon MonoxideIBA
02/2009
1ProgesteroneFDA LinkGeneric
08/2006
1Fibronectins (Fibronectin)IBA
08/2002

Therapy/Procedure

8Hysterectomy
11/2013 - 01/2002
3Uterine Artery Embolization
01/2014 - 01/2012
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
01/2014
1General Anesthesia
01/2011
1Conscious Sedation
01/2011
1Aftercare (After-Treatment)
01/2011
1Endometrial Ablation Techniques
01/2011
1Analgesia
01/2010
1Retreatment
02/2009
1Cervical Cerclage
08/2006
1Estrogen Replacement Therapy
03/2006